Revlimid and Vith nerve paralysis - a phase IV clinical study of FDA data

Summary:

Vith nerve paralysis is reported as a side effect among people who take Revlimid (lenalidomide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Thalidomide, and have Sleep disorder.

The phase IV clinical study analyzes which people have Vith nerve paralysis when taking Revlimid. It is created by eHealthMe based on reports of 377,717 people who have side effects when taking Revlimid from the FDA, and is updated regularly.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.

What is Vith nerve paralysis?

Vith nerve paralysis is found to be associated with 141 drugs and 379 conditions by eHealthMe. Check the latest studies of Vith nerve paralysis.

On Jul, 11, 2026

377,717 people reported to have side effects when taking Revlimid.
Among them, 20 people (0.01%) have Vith nerve paralysis.

Could Revlimid cause Vith nerve paralysis?

Among these 20 people:

How long have people been on Revlimid when they have Vith nerve paralysis? *

What is the gender of people who have Vith nerve paralysis when taking Revlimid? *

female: 30 %
male: 70 %

What is the age of people who have Vith nerve paralysis when taking Revlimid? *

What are other drugs people take besides Revlimid? *

What are other side effects people have besides Vith nerve paralysis? *

Malignant Neoplasm Progression (cancer tumour came back): 9 people, 45.00%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 20.00%
Pain In Extremity: 3 people, 15.00%
Dyspnea (difficult or laboured breathing): 3 people, 15.00%
Left Ventricular Dysfunction: 2 people, 10.00%
Dilatation Ventricular: 2 people, 10.00%
Neoplasm Malignant (cancer tumour): 2 people, 10.00%
Cerebral Atrophy (decrement in size of brain): 2 people, 10.00%
Cerebral Small Vessel Ischaemic Disease (inadequate blood supply to small blood vessel of brain): 2 people, 10.00%
Compression Fracture (fracture due to pressure caused by injury): 2 people, 10.00%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 2 people, 10.00%
Sleep Disorder: 2 people, 10.00%
Stress And Anxiety: 1 person, 5.00%
Headache (pain in head): 1 person, 5.00%
Accidental Exposure: 1 person, 5.00%
Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 1 person, 5.00%
Birth Control: 1 person, 5.00%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 1 person, 5.00%
Bone Pain: 1 person, 5.00%
Cardiac Disorder: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Revlimid and have Vith nerve paralysis?

- Check whether Vith nerve paralysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Revlimid:

Revlimid (378,026 reports)

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vith nerve paralysis:

Vith nerve paralysis (141 drugs)

Browse all the conditions that are associated with Vith nerve paralysis:

Vith nerve paralysis (379 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Revlimid) and Revlimid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.